Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's RWE Data Working Group.
Curr Oncol. 2022 Mar 17;29(3):2046-2063. doi: 10.3390/curroncol29030165.
Curr Oncol. 2022.
PMID: 35323365
Free PMC article.
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Dai WF, Craig E, Fraser B, Chambers A, Mai H, Brown MB, Earle CC, Evans WK, Geirnaert M, Taylor M, Trudeau M, Sperber D, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration.
Dai WF, et al. Among authors: on behalf of the canrevalue collaboration.
Curr Oncol. 2021 Nov 12;28(6):4645-4654. doi: 10.3390/curroncol28060392.
Curr Oncol. 2021.
PMID: 34898572
Free PMC article.
Item in Clipboard
Cite
Cite